Abstract:As a chronic metabolic disease, diabetes mellitus (DM) is broadly characterized by elevated levels of blood glucose. Novel epidemiological studies demonstrate that some diabetic patients have an increased risk of developing dementia compared with healthy individuals. Alzheimer’s disease (AD) is the most frequent cause of dementia and leads to major progressive deficits in memory and cognitive function. Multiple studies have identified an increased risk for AD in some diabetic populations, but it is still unclear which diabetic patients will develop dementia and which biological characteristics can predict cognitive decline. Although few mechanistic metabolic studies have shown clear pathophysiological links between DM and AD, there are several plausible ways this may occur. Since AD has many characteristics in common with impaired insulin signaling pathways, AD can be regarded as a metabolic disease. We conclude from the published literature that the body’s diabetic status under certain circumstances such as metabolic abnormalities can increase the incidence of AD by affecting glucose transport to the brain and reducing glucose metabolism. Furthermore, due to its plentiful lipid content and high energy requirement, the brain’s metabolism places great demands on mitochondria. Thus, the brain may be more susceptible to oxidative damage than the rest of the body. Emerging evidence suggests that both oxidative stress and mitochondrial dysfunction are related to amyloid- β (A β ) pathology. Protein changes in the unfolded protein response or endoplasmic reticulum stress can regulate A β production and are closely associated with tau protein pathology. Altogether, metabolic disorders including glucose/lipid metabolism, oxidative stress, mitochondrial dysfunction, and protein changes caused by DM are associated with an impaired insulin signal pathway. These metabolic factors could increase the prevalence of AD in diabetic patients via the promotion of A β pathology.

Understanding the Link and Implications

Molecular Linkages Between Diabetes and Alzheimer's Disease: Current Scenario and Future Prospects

Is Alzhezimer’s disease a New Type Diabetes? Crosstalk between two serious disorders: review

Association Between Type 2 Diabetes Mellitus and Alzheimer's Disease: Common Molecular Mechanism and Therapeutic Targets

Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation.

Link between Diabetes and Alzheimer’s Disease Due to the Shared Amyloid Aggregation and Deposition Involving Both Neurodegenerative Changes and Neurovascular Damages

Proteomics Approaches to Understand Linkage Between Alzheimer's Disease and Type 2 Diabetes Mellitus.

Fighting Alzheimer&#39;s Disease and Type 2 Diabetes: Pathological Links and Treatment Strategies

Neurometabolic Evidence Supporting the Hypothesis of Increased Incidence of Type 3 Diabetes Mellitus in the 21st Century

Emerging Pathophysiological Mechanisms Linking Diabetes Mellitus and Alzheimer's Disease: An Old Wine in a New Bottle

Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes

Biological Mechanisms Linking Alzheimer'S Disease And Type-2 Diabetes Mellitus

Epigenomic Approach In Understanding Alzheimer'S Disease And Type 2 Diabetes Mellitus

An update on potential links between type 2 diabetes mellitus and Alzheimer’s disease

Alzheimer's Disease and Type 2 Diabetes Via Chronic Inflammatory Mechanisms.

Genomic linkage between Alzheimer's disease and type 2 diabetes.

The Diabetic Brain and Cognition

Neurodegeneration in type 2 diabetes: Alzheimer's as a case study

Metabolism: A Novel Shared Link Between Diabetes Mellitus and Alzheimer’s Disease

Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease

Insulin resistance as the molecular link between diabetes and Alzheimer's disease